Ri-1Homo sapiens (Human)Cancer cell line

Also known as: Riva, RIVA, RI1, RI-1

🤖 AI SummaryBased on 12 publications

Quick Overview

Ri-1 is a human leukemia/lymphoma cell line with potential applications in cancer research.

Detailed Summary

Ri-1 is a human leukemia/lymphoma cell line that has been characterized in multiple studies. It is derived from a patient with B-cell lymphoma/leukemia and has been used in research to study genetic and molecular mechanisms of cancer. The cell line exhibits specific chromosomal abnormalities, including a 14q+ abnormality, which is associated with certain types of lymphomas. Ri-1 has been utilized in studies involving gene expression profiling, protein analysis, and drug sensitivity testing. It is part of a panel of cell lines used to investigate the pathogenesis of B-cell malignancies and to develop targeted therapies. The cell line's genetic and phenotypic characteristics make it a valuable tool for understanding the molecular basis of leukemia and lymphoma.

Research Applications

Cancer researchGenetic and molecular studiesDrug sensitivity testingGene expression profiling

Key Characteristics

14q+ abnormalityB-cell lineageUsed in studies of B-cell malignancies
Generated on 6/17/2025

Basic Information

Database IDCVCL_1885
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age57
Age CategoryAdult
SexFemale

Disease Information

DiseaseDiffuse large B-cell lymphoma
LineageLymphoid
SubtypeActivated B-cell Type
OncoTree CodeABC

DepMap Information

Source TypeDSMZ
Source IDACH-000398_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Glu294Ter (c.880G>T)Unspecified-PubMed=12872257
MutationSimpleTP53p.Lys132Arg (c.395A>G)Unspecified-PubMed=34732238

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D13S317
9,14
D16S539
11,12
D18S51
16
D19S433
14,15
D21S11
30
D2S1338
17,23
D3S1358
16
D5S818
11
D7S820
9,13
D8S1179
10,13
FGA
22,25
Penta D
11,12
Penta E
7,11
TH01
6
TPOX
8
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

The LL-100 panel: 100 cell lines for blood cancer studies.";

MacLeod R.A.F., Nagel S., Steube K.G., Uphoff C.C., Drexler H.G.

Sci. Rep. 9:8218-8218(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Screening human cell lines for viral infections applying RNA-Seq data analysis.

Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

PLoS ONE 14:E0210404-E0210404(2019).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas.

Drexler H.G., Eberth S., Nagel S., MacLeod R.A.F.

Leuk. Lymphoma 57:1015-1020(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.

O'Grady T., Baddoo M., Fewell C., Renne R., Flemington E.K.

J. Virol. 89:713-729(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.

Martinez-Climent J.A.

Blood 109:271-280(2007).

Frameshift mutations of the hMSH6 gene in human leukemia cell lines.

Hirai H.

Jpn. J. Cancer Res. 89:33-39(1998).

The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.

Quentmeier H., Drexler H.G.

Leukemia 10:142-149(1996).

Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid phosphatase.

Drexler H.G., Gaedicke G., Minowada J.

Leuk. Res. 9:537-548(1985).

Isoenzyme studies in human leukemia-lymphoma cell lines -- III. Beta-hexosaminidase (E.C. 3.2.1.30).

Drexler H.G., Gaedicke G., Minowada J.

Leuk. Res. 9:549-559(1985).

Establishment and characterization of three new malignant lymphoid cell lines.

White H., Catovsky D., Foroni L., Luzzatto L., Goldman J.M.

Int. J. Cancer 39:89-93(1987).

Isoenzyme studies in human leukemia-lymphoma cell lines -- 1. carboxylic esterase.

Drexler H.G., Gaedicke G., Minowada J.

Leuk. Res. 9:209-229(1985).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).

Web Resources